innate immune cells (alveolar macrophages, neutrophils, dendritic cells) dynamically switch between apoptosis, necroptosis, and pyroptosis, and their balance directly affects whether inflammation progresses towards resolution or persistent activation
Mobli M, Morgenstern D, King GF, Alewood PF, Muttenthaler M
It is not a medication, and it does not contain GLP-1 or GLP-1 receptor agonists
Additionally, in phase 2 studies in people with MASH and liver fibrosis, survodutide not only significantly improved liver steatosis, but also led to histologic improvement of MASH without worsening fibrosis in 4362% of participants, versus 14% with placebo [41]
The following information is based on ProHealth Longevity's publicly available product materials, along with referenced preclinical research and current regulatory context